🇺🇸 FDA
Patent

US 7521177

Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence

granted A61KA61K2039/53A61K2039/70

Quick answer

US patent 7521177 (Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K48/00